Cargando…
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
Preclinical animal studies have convincingly demonstrated that tumor immunity to self antigens can be actively induced and can translate into an effective anti-tumor response. Several of these observations are being tested in clinical trials. Immunization with xenogeneic DNA is an attractive approac...
Autores principales: | Srinivasan, Roopa, Wolchok, Jedd D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419720/ https://www.ncbi.nlm.nih.gov/pubmed/15090064 http://dx.doi.org/10.1186/1479-5876-2-12 |
Ejemplares similares
-
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
por: Yuan, Jianda, et al.
Publicado: (2013) -
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014) -
The future of cancer immunotherapy: microenvironment-targeting combinations
por: Murciano-Goroff, Yonina R., et al.
Publicado: (2020) -
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
por: Franzese, Ornella, et al.
Publicado: (2017) -
Immunotherapy and the belly of the beast
por: Merghoub, Taha, et al.
Publicado: (2014)